我们的网站为什么显示成这样?

可能因为您的浏览器不支持样式,您可以更新您的浏览器到最新版本,以获取对此功能的支持,访问下面的网站,获取关于浏览器的信息:

|本期目录/Table of Contents|

动脉导管未闭并重度肺动脉高压封堵术后肺动脉压力变化

《心脏杂志》[ISSN:1009-7236/CN:61-1268/R]

期数:
2014年第6期
页码:
708-712
栏目:
临床研究
出版日期:
2014-06-25

文章信息/Info

Title:
Changes of pulmonary artery pressure after transcatheter closure of patent ductus arteriosus complicated with severe pulmonary arterial hypertension
作者:
张端珍朱鲜阳崔春生侯传举王琦光
(沈阳军区总医院先心病内科,辽宁 沈阳 110840)
Author(s):
ZHANG Duan-zhen ZHU Xian-yang CUI Chun-sheng HOU Chuan-ju WANG Qi-guang
(Department of Congenital Heart Disease, General Hospital, Shenyang Military Area Command, Shenyang 110840, Liaoning, China)
关键词:
动脉导管未闭肺动脉高压介入治疗心脏病先天性
Keywords:
patent ductus arteriosus pulmonary arterial hypertension interventional therapy congenital heart disease
分类号:
R541.1
DOI:
-
文献标识码:
A
摘要:
目的:探讨动脉导管未闭(patent ductus arteriosus,PDA)并发重度肺动脉高压(pulmonary arterial hypertension,PAH)经导管封堵术后肺动脉压力(pulmonary artery pressure,PAP)变化及其与术后PAH的关系。方法: 对111例肺动脉平均压(mean pulmonary artery pressure,mPAP)>55 mmHg,肺/体循环血量比值(Qp/Qs)>1.5的PDA患者实施封堵术,术中实时监测封堵术前后PAP变化,术后定期随访并行超声心动图检查。结果: 所有患者均成功实施封堵术,术后即刻PAP显著降低(P<0.05),但mPAP恢复正常仅37例(33.3%),另有轻度、中度和重度PAH患者51(49.5%),14(12.6%)和9例(8.1%)。随访1~8(中位数4)年。术后3个月共24例(21.6%)患者存在PAH,其中9例术后6个月PAP恢复正常,另外15例(13.5%)PAH持续存在。术后PAP最终恢复正常的患者封堵术后即刻mPAP降低(59±10)%,术后存在持续性PAH者仅降低(24±14)%。术后即刻PAP正常和轻度PAH者术后PAP最终均恢复正常,而术后即刻存在重度PAH者随访期间PAH持续存在。结论: 在并发重度PAH的PDA患者中,即使Qp/Qs>1.5,仍有13.5%的患者存在术后持续性PAH;关闭PDA后导管测量PAP为重度PAH者,术后PAH不可避免;如果术后6个月PAP仍然高于正常,PAH将持续存在。
Abstract:
AIM:To evaluate the changes of pulmonary artery pressure (PAP) in patients with patent ductus arteriosus (PDA) and severe pulmonary arterial hypertension (PAH) after transcatheter device closure. METHODS: Transcather closure of PDA was performed in 111 patients with mean PAP (mPAP) >55 mmHg and pulmonary-to-systemic flow ratio (Qp/Qs) >1.5. PAP and aortic pressure were measured before and after device closure. Patients were followed clinically and with echocardiogram. RESULTS: All patients underwent successful transcatheter closure of PDA without major complications. PAP fell significantly (P<0.05) after device closure of PDA, but mPAP restored to normal level in only 37 patients (33.3%) immediately after PDA closure, and mild, moderate and severe PAH was, respectively, observed in 51, 14 and nine patients. The follow-up period was 1-8 (median 4) years. Twenty-four patients had PAH at 3 months after procedure but only 15 (13.5%) of them had PAH at 6 months, which was persistent during the whole follow up. Device closure resulted in drop in mPAP by (59±10)% in patients without PAH but only (24±14)% in patients with persistent post-procedural PAH (P<0.05). None of the patients with normal PAP and mild PAH but patients with severe PAH after PDA closure before device release had persistent post-procedural PAH. CONCLUSION: In patients with PDA and severe PAH, 13.5% will have persistent post-procedural PAH, although the pre-procedural Qp/Qs ratio is>1.5. Persistent post-procedural PAH will be inevitable in patients with severe PAH immediately after PDA closure and PAH will be persistent if the PAP is still higher than normal 6 months after procedure.

参考文献/References

[1]Schneider DJ,Moore JW.Patent ductus arteriosus[J].Circulation,2006,114(17):1873-1882.
[2]Baumgartner H,Bonhoeffer P,De Groot NM,et al.ESC Guidelines for the management of grown-up congenital heart disease[J].Eur Heart J,2010,31(23):2915-2957.
[3]Berger M,Haimowitz A,Van Tosh A,et al.Quantitative assessment of pulmonary hypertension in patients with tricuspid regurgitation using continuous wave Doppler ultrasound[J].J Am Coll Cardiol,1985,6(2):359-365.
[4]Sánchez-Recalde A,Oliver JM,Galeote G,et al.Atrial septal defect with severe pulmonary hypertension in elderly patients:usefulness of transient balloon occlusion[J].Rev Esp Cardiol,2010,63(7):860-864.
[5]Galie N,Manes A,Palazzini M,et al.Management of pulmonary arterial hypertension associated with congenital systemic-to-pulmonary shunts and Eisenmenger's syndrome[J].Drugs,2008,68(8):1049-1066.
[6] Frescura C,Thiene G,Giulia Gagliardi M,et al.Is lung biopsy useful for surgical decision making in congenital heart disease?[J].Eur J Cardiothorac Surg,1991,5(3):118-122.
[7]Huang JB,Liu YL,Yu CT,et al.Lung biopsy findings in previously inoperable patients with severe pulmonary hypertension associated with congenital heart disease[J].Int J Cardiol,2011,151(1):76-83.
[8]Beghetti M.Congenital heart disease and pulmonary hypertension[J].Rev Port Cardiol,2004,23(2):273-281.
[9]Bando K,Turrentine MW,Sharp TG,et al.Pulmonary hypertension after operations for congenital heart disease: analysis of risk factors and management[J].J Thorac Cardiovasc Surg,1996,112(6):1600-1607.
[10]Yan C,Zhao S,Jiang S,et al.Transcatheter closure of patent ductus arteriosus with severe pulmonary arterial hypertension in adults[J].Heart,2007,93(4):514-518.
[11]Naeije R,Torbicki A.More on the noninvasive diagnosis of pulmonary hypertension: Doppler echocardiography revisited[J].Eur Respir J,1995,8(9):1445-1449.
[12]Currie PJ,Seward JB,Chan KL,et al.Continuous wave Doppler determination of right ventricular pressure:a simultaneous Doppler-catheterization study in 127 patients[J].J Am Coll Cardiol,1985,6(4):750-756

备注/Memo

备注/Memo:
收稿日期:2014-01-12.
作者简介:张端珍,副主任医师,博士Email:meichengzhang123@163.com
更新日期/Last Update: 2014-07-10